Update on D-ala-peptide T-amide (DAPTA): a viral entry inhibitor that blocks CCR5 chemokine receptors.

Current HIV research

Volumn 1, Issue 1, 2003, Pages 51-67

  Ruff, Michael R ^a   Polianova, Maria ^a   Yang, Quan en ^a   Leoung, Gifford S ^a   Ruscetti, Francis W ^a   Pert, Candace B ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; PEPTIDE T; PEPTIDE T AMIDE; VIRUS RECEPTOR;

DRUG ANTAGONISM; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PHASE 2 CLINICAL TRIAL; REVIEW; VIRUS REPLICATION;

CLINICAL TRIALS, PHASE II; HIV INFECTIONS; HIV-1; HUMANS; PEPTIDE T; RECEPTORS, CCR5; RECEPTORS, HIV; VIRUS REPLICATION;

EID: 0141713810     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570162033352066     Document Type: Review

References (104)